Preventing Medical Errors in Patient Identity Through Data Matching, VBC, and Interoperability Standards
[Sponsored] A webinar, sponsored by Verato, offered a robust discussion with executives from Providence, Yale…
[Sponsored] A webinar, sponsored by Verato, offered a robust discussion with executives from Providence, Yale New Haven Health System and Verato on navigating an increasingly complex landscape of sharing electronic patient data. The post Preventing Medical Errors in Patient Identity Through Data Matching, VBC, and Interoperability Standards appeared first on MedCity News.
Kelly Haggett figures that a mandatory surcharge added to Washington state’s payroll tax cost her about $500 last year. But she doesn’t really mind. “On a scale of 1 to 10 of my annoyance with taxes in general, this one is about a 2,” she said. “I see the benefits.” The small surcharge on wages…
Seasonal work. Inconsistent hours. Frequent moves. Cash payments and informal jobs. For farmworkers who rely on Medicaid, these common employment patterns could put their health coverage at risk. It’s a heightened concern for the estimated million-plus farmworkers who are U.S. citizens or legal permanent residents, as new work requirements kick in for the federal-state healthcare…
By DAMIAN WONJO Every clinician keeps a private list of the patients they don’t see. Not the ones who cancel, the ones who never book. The shift worker who reschedules the same appointment three times and then quietly gives up. The parent who can’t justify half a day off and a waiting-room afternoon for a…
IKS Health acquired TruBridge for $557 million, folding the rural-hospital-focused EHR and revenue cycle company into its AI-powered care platform. It’s IKS’ third acquisition this year. The post IKS Health Beefs Up Its Tech Stack with $557M Acquisition of TruBridge appeared first on MedCity News.
KFF found that ACA Marketplace insurers are proposing a median 14% premium increase for 2027, driven by rising healthcare costs and the expiration of enhanced premium tax credits. The post ACA Marketplace Insurers Propose 14% Median Premium Increase in 2027 appeared first on MedCity News.
AstraZeneca and Ionis Pharmaceuticals drug eplontersen, brand name Wainua, failed a Phase 3 test in cardiomyopathy caused by transthyretin amyloidosis. More details will be shared at a medical conference next month, but it appears the RNA therapy’s slim hopes now ride on a subgroup analysis. The post Phase 3 Failure Keeps AstraZeneca and Ionis Out…
As SUD IMD waiver evaluations and renewals are becoming available, states face a shifting Medicaid and policy and waiver landscape. This brief examines findings from the first available summative evaluations for SUD IMD waivers and what they show about progress toward meeting goals and milestones.
For someone already managing chronic disease, menopause can disrupt stability and complicate treatment plans in ways that aren’t always immediately visible but show up over time in outcomes and utilization. The post Menopause Is an Overlooked Driver of Cost in High-Risk Populations appeared first on MedCity News.